TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+11.82%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$328M
AUM Growth
+$328M
(+45%)
Cap. Flow
+$89.2M
Cap. Flow
% of AUM
27.18%
Top 10 Holdings %
Top 10 Hldgs %
53.81%
Holding
92
New
24
Increased
8
Reduced
15
Closed
42
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$35.7M |
| 2 |
Abbott
ABT
|
$17.7M |
| 3 |
Tandem Diabetes Care
TNDM
|
$17M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$14.8M |
| 5 |
Illumina
ILMN
|
$14.6M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$12.1M |
| 2 |
West Pharmaceutical
WST
|
$10.5M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$9.55M |
| 4 |
Celldex Therapeutics
CLDX
|
$7.85M |
| 5 |
Stevanato
STVN
|
$7.68M |
Sector Composition
| 1 | Healthcare | 95.57% |
| 2 | Energy | 0.07% |
| 3 | Real Estate | 0.03% |
| 4 | Materials | 0.02% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Astria Therapeutics
ATXS
$349M
| $3.66M | 1.11% |
275,011
-376,319
| -58% | -$5.01M |
|
27
Akero Therapeutics
AKRO
$3.74B
| $3.39M | 1.03% |
88,524
-40,327
| -31% | -$1.54M |
|
28
X4 Pharmaceuticals
XFOR
$84.2M
| $3.37M | 1.03% |
3,878,484
+171,967
| +5% | +$150K |
|
29
Madrigal Pharmaceuticals
MDGL
$9.76B
| $3.35M | 1.02% |
13,845
-12,541
| -48% | -$3.04M |
|
30
Viking Therapeutics
VKTX
$3.04B
| $3.33M | 1.01% |
+200,000
| New | +$3.33M |
|
31
Beam Therapeutics
BEAM
$1.66B
| $3.28M | 1% |
107,230
+25,212
| +31% | +$772K |
|
32
Protagonist Therapeutics
PTGX
$3.67B
| $3.07M | 0.93% |
+133,452
| New | +$3.07M |
|
|
RXDX
33
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $3.06M | 0.93% |
+28,470
| New | +$3.06M |
|
|
ISEE
34
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.6M | 0.79% |
106,711
-136,368
| -56% | -$3.32M |
|
35
Roivant Sciences
ROIV
$8.15B
| $2.54M | 0.77% |
+344,530
| New | +$2.54M |
|
36
89bio
ETNB
$1.34B
| $2.39M | 0.73% |
+157,225
| New | +$2.39M |
|
37
Altimmune
ALT
$338M
| $2.23M | 0.68% |
528,814
+203,120
| +62% | +$857K |
|
38
Praxis Precision Medicines
PRAX
$958M
| $2.01M | 0.61% |
2,488,354
+2,464,207
| +10,205% | +$1.99M |
|
|
VRNA
39
Verona Pharma
VRNA
$9.16B
| $1.96M | 0.6% |
+97,814
| New | +$1.96M |
|
40
Evolus
EOLS
$494M
| $1.36M | 0.41% |
+160,269
| New | +$1.36M |
|
41
Femasys
FEMY
$11.6M
| $137K | 0.04% |
126,482
+23,735
| +23% | +$25.8K |
|
42
Antero Midstream
AM
$8.51B
| $117K | 0.04% |
11,114
-4,039
| -27% | -$42.4K |
|
43
B2Gold
BTG
$5.46B
| $75.2K | 0.02% |
+19,076
| New | +$75.2K |
|
|
PGRE
44
Paramount Group
PGRE
$1.59B
| $68.4K | 0.02% |
+15,008
| New | +$68.4K |
|
|
ETRN
45
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $58.6K | 0.02% |
+10,131
| New | +$58.6K |
|
|
SWN
46
DELISTED
Southwestern Energy Company
SWN
| $51.8K | 0.02% |
+10,357
| New | +$51.8K |
|
|
UNIT
47
Uniti Group
UNIT
$1.55B
| $40.4K | 0.01% |
11,370
-1,121
| -9% | -$3.98K |
|
48
Passage Bio
PASG
$22.7M
| – | – |
-22,661
| Closed | -$31K |
|
|
AHH
49
Armada Hoffler Properties
AHH
$584M
| – | – |
-14,573
| Closed | -$168K |
|
|
AIV
50
Aimco
AIV
$1.11B
| – | – |
-14,169
| Closed | -$101K |
|